Related Experiment Video
Updated: Apr 18, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
[Betatrophin - the turn in diabetes treatment]
Abstract:
The topic of the present work is the appearance of the newest research in diabetes treatment. Till now, the patients were forced to inject insulin or take oral medicines to maintain proper glucose level. Introduction of the incretin group of medicines to the market turned out to be a breakthrough in diabetes treatment. It defers the necessity of insulin therapy in type 2 diabetes. Studies connected with amyline were the next step in diabetes therapy. The new research connected with peptide betatrophin seems to comes as the biggest surprise and hope for diabetics. The hormone stimulates B-cells proliferation, which leads to increase in endogenous insulin production. It generates a chance for a fewer number of injections, which will result in better quality of life.
More Related Videos
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Dipeptidyl Peptidase 4 Inhibitors